Novo Nordisk A/S
OTC:NONOF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novo Nordisk A/S
OTC:NONOF
|
DK |
|
F
|
Ferrexpo PLC
OTC:FEEXY
|
CH |
|
Proact IT Group AB
F:PIU0
|
SE |
|
S
|
Siemens Healthineers AG
XMUN:SHL
|
DE |
|
N
|
Norsk Hydro ASA
XHAM:NOH1
|
NO |
|
Verisk Analytics Inc
F:VA7A
|
US |
Wall St Price Targets
NONOF Price Targets Summary
Novo Nordisk A/S
According to Wall Street analysts, the average 1-year price target for NONOF is 50.07 USD with a low forecast of 30.86 USD and a high forecast of 72.83 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NONOF's stock price target?
Price Target
50.07
USD
According to Wall Street analysts, the average 1-year price target for NONOF is 50.07 USD with a low forecast of 30.86 USD and a high forecast of 72.83 USD.
What is the Revenue forecast for Novo Nordisk A/S?
Projected CAGR
1%
Over the last 14 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 1%.
What is the Gross Profit forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 12%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Novo Nordisk A/S?
Projected CAGR
2%
Over the last 14 years, the compound annual growth rate for Operating Income has been 13%. The projected CAGR for the next 3 years is 2%.
What is the Pre-Tax Income forecast for Novo Nordisk A/S?
Projected CAGR
0%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 14%. The projected CAGR for the next 3 years is 0%.
What is the Net Income forecast for Novo Nordisk A/S?
Projected CAGR
-1%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 3 years is -1%.
